The role of the microsomal triglyceride transfer protein in abetalipoproteinemia

Annual Review of Nutrition

Volumn 20, Issue , 2000, Pages 663-697

  Berriot Varoqueaux, N ^a   Aggerbeck, L P ^a   Samson Bouma, M E ^a   Wetterau, J R ^a  

^a INSERM   (France)

Author keywords

Apolipoprotein B; Cholesterol; Plasma lipoproteins; Protein disulfide isomerase; Vitamin E

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL ESTER; CHYLOMICRON; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ALPHA TOCOPHEROL; APOLIPOPROTEIN B;

ABETALIPOPROTEINEMIA; CLINICAL FEATURE; GENE MUTATION; HUMAN; LIPID METABOLISM; MALNUTRITION; MEMBRANE COMPONENT; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; VITAMIN DEFICIENCY; BLOOD; CHEMISTRY; GENETICS; INTESTINE; LIVER; MALABSORPTION; METABOLISM; MICROSOME; NUTRITIONAL DISORDER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ABETALIPOPROTEINEMIA; APOLIPOPROTEINS B; AVITAMINOSIS; CARRIER PROTEINS; HUMANS; INTESTINES; LIPID METABOLISM; LIVER; MALABSORPTION SYNDROMES; MICROSOMES; NUTRITION DISORDERS; TRIGLYCERIDES; VITAMIN E;

EID: 0033826953     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.20.1.663     Document Type: Review

References (215)

1. Lipoproteins containing apolipoprotein B isolated from patients with abetalipoproteinemia: Identification and characterization
2. A case report of abetalipoproteinemia (Bassen-Kornzweig syndrome): The first case in Japan
3. Regulation of cholesterol synthesis by plasma lipoproteins from patients with abetalipoproteinemia
4. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver
5. Crystal structure of lamprey lipovitellin, a member of a novel class of lipid-carrying proteins
6. Tocopherol transfer protein stimulates the secretion of tocopherol from a cultured liver cell line through a brefeldin A-insentive pathway
7. Identification of two classes of lipid molecule binding sites on the microsomal triglyceride transfer protein
8. Morphologic features of the liver in abetalipoproteinemia
9. Platelet function in a case of abetalipoproteinemia
10. Abetalipoproteinemia treated with parenteral and oral vitamins A, E, with medium chain triglycerides
11. Absence congenitale de betalipoproteines
12. Molecular species of phosphatidylcholine in abetaliproteinemia: Effect of lecithin: Cholesterol acyltransferase and lysolecithin acyltransferase
13. Importance of cholesterol-phospholipid interaction in determining dynamics of normal and abetalipoproteinemia red blood cell membrane
14. Neutral lipids of plasma and adipose tissue in abetalipoproteinemia
15. Malformation of the erythrocytes in a case of atypical retinis pigmentosa
16. Abetalipoproteinemia. Report of a case
17. Congenital absence of betalipoproteins: Unusual and peculiar syndrome. A recent case
18. Safety of oral intake Of Vitamin E
19. Hepatic microsomal triglyceride transfer protein messenger RNA concentrations are increased by dietary cholesterol in hamsters
20. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein
21. Vitamin E
22. Vitamin A, vitamin E replacement in abetalipoproteinemia
23. Combined vitamin A, E therapy prevents retinal electrophysiological deterioration in abetalipoproteinemia
24. Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia
25. Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia
26. Abetalipoproteinamie bei drei Geschwistern
27. ApoB100-containing lipoproteins are secreted by the heart
28. Ultrastructural localization of apoB and apoC binding to very low density lipoproteins in rat liver
29. Description of two different patients with abetalipoproteinemia: Synthesis of a normal-sized apolipoprotein B-48 in intestinal organ culture
30. A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase
31. Neuropathology of abetalipoproteinemia: A possible complication of the tocopherol (vitamin E) deficiency state
32. Electrophysiological features of abetalipoproteinemia: Functional consequences of vitamin E deficiency
33. Vitamin E: Antioxidant activity, biokinetics, and bioavailability
34. Abetalipoproteinemia presenting as severe K deficiency
35. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse
36. Manifestations ophtalmologiques d'un syndrome de Bassen-Kornzweig. A propos d'un cas
37. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles AI, AII and particles AI but not AII
38. Interaction between high-density lipoprotein subpopulation in apoB-free and abetalipoproteinemic plasma
39. Ocular abnormalities in abetalipoproteinemia
40. Primary aberrant regeneration of the oculomotor nerve. Occurrence in a patient with abetalipoproteinemia
41. Hepatic peroxisomal abnormalities in abetalipoproteinemia
42. Decreased fluidity of red cell membrane lipids in abetalipoproteinemia
43. The relationship between serum lipoproteins and red cell membranes in abetalipoproteinemia deficiency of lecithin cholesterol acyltransferase
44. Platelet and neutophil function and eicosanoid release in a subject with abetalipoproteinemia
45. Abnormal high density lipoproteins of abetalipoproteinemia: Relevance to normal HDL metabolism
46. Endoscopic assessment in abetalipoproteinemia
47. The cardiac lesion in Bassen-Kornzweig syndrome
48. An ultrastructural study of the intestinal mucosa in congenital lipoprotein deficiency with particular emphasis upon the intestinal absortive cell
49. Peroxydative hemolysis of red blood cells from patients with abetalipoproteinemia
50. Un cas nouveau d'acanthocytose. Dysmorphie erythrocytaire congenitale avec retinite, troubles nerveux et stigmates degeneratifs
51. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia
52. Angioid streaks associated with abetalipoproteinemia. Case report
53. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia
54. Clinical experience with R103757, a potent inhibitor of microsomal triglyceride transfer protein (MTP)
55. A-betalipoproteinaemia. Ocular involvement in a Danish case
56. Longitudinal multimodal evoked potential studies in abetalipoproteinemia
57. Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells
58. The protein disulphide-isomerase family: Unravelling a string of folds
59. Purification and substrate specificity of lecithin-cholesterol acyltransferase from human plasma
60. Vitamin E deficiency in the monkey
61. Abetalipoproteinemia
62. Formation of phospholipid-rich HDL: A model for square-packing lipoprotein particles found in interstitial fluid and in abetalipoproteinemic plasma
63. L'absence congenitale de beta-lipoprotenes: Etude de l'absorption des graisses apres exsanguino-transfusion et mesure de la demi-vie des betalipoproteines injectees
64. Hypocholesterolemia in idiopathic steatorrhea
65. Apolipoprotein synthesis in normal and abetalipoproteinemic intestinal mucosa
66. Immunofluorescence studies of apolipoprotein B in intestinal mucosa. Absence in abetaliproproteinemia
67. Cholesterol turn-over and metabolism in two patients with abetalipoproteinemia
68. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step
69. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability
70. Angioid streaks associated with abetalipoproteinemia
71. On the protein defect in abetalipoproteinemia
72. Retinitis pigmentosa in abetalipoproteinemia: Effects of vitamin A
73. Hypocholesterolemia in childhood
74. Apolipoprotein (a) can be detected in plasma independent of apolipoprotein B
75. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes: Cell type-specific expression and response to metabolic regulators
76. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2)
77. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency
78. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption
79. Introduction: Structure and metabolism of plasma lipoproteins
80. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A
81. The use of highly informative CA repeat polymorphism within the abetaliproteinaemia locus (4q22-24)
82. Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy
83. Docosahexanoic acid and the development and function of the infant retina
84. Histochemical and ultrastructural pathology of skeletal muscle in a patient with abetalipoproteinemia
85. Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes
86. Free apolipoprotein (a) in abetalipoproteinemia
87. Congenital lack of serum beta lipoproteins: A study of blood phospholipids in a patient and his family
88. Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia
89. Amino acids 430-570 in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein
90. Alterations in erythrocyte membrane lipids in abetalipoproteinemia: Phospholipid and fatty acyl composition
91. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: Implications for the roles of apolipoproteins B and E in HDL metabolism
92. Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia
93. Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia
94. High density lipoprotein metabolism in a patient with abetalipoproteinemia
95. Lipid metabolism in abetalipoproteinemia: A study of cholesterol absorption and sterol balance in two patients
96. Abetalipoproteinemia. Report of two cases and review of therapy
97. Corticosteroid production in abetalipoproteinemia: Evidence for an impaired response to ACTH
98. Folding of the amino-terminal domain of apolipoprotein B initiates microsomal triglyceride transfer protein-dependent lipid transfer to nascent very low density lipoprotein
99. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma
100. Congenital betalipoprotein deficiency: An hereditary disorder involving a defect in the absorption and transport of lipids
101. Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoprotein in hepatic cells
102. Microsomal triglyceride transfer protein: Specificity of lipid binding and transport
103. An inhibitor of the microsomal triglyceride transfer protein inhibits apo B secretion from HepG2 cells
104. Atypical retinis pigmentosa, acanthrocytosis and heredodegerative neuromuscular disease
105. Somatosensory evoked potentials in abetalipoproteinemia
106. Abnormalities of high density liporoteins in abetaliproteinemia
107. Abetalipoproteinemia: Report of an unusual patient
108. A case of abetalipoproteinemia in a Polish family
109. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins
110. Is essential fatty acid deficiency part of the syndrome of abetalipoproteinemia?
111. The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: Normal and abetalipoprotenemic subjects
112. The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis
113. Clinical nutritional and biochemical consequences of apolipoprotein B deficiency
114. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
115. Abetalipoproteinemia and colour-blindness
116. Ultrastructural changes in skeletal muscle of a patient with familial intrahepatic cholestasis associated with vitamin E deficiency
117. Retinis pigmentosa, acanthrocytosis and heredodegerative neuromuscular disease
118. Investigation of serum lipoproteins and apoproteins in abetalipoproteinemia
119. Abetalipoproteinemia: Muscle involvement
120. Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia
121. L'absence congenitale de betalipoproteines
122. Absence congenitale de betalipoproteines
123. Muscle pathology in Bassen-Kornzweig syndrome and vitamin E deficiency
124. Low density lipoprotein degradation by mononuclear cells from normal and dyslipoproteinemic subjects
125. Microsomal triglyceride transfer protein, the abetalipoprotein gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells
126. Absence of intestinal synthesis of apolipoprotein B-48 in two cases of abetalipoproteinemia
127. The lipoproteins and lipid transport in abetalipoproteinemia
128. Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): Mechanistic studies on the role of MTP in apolipoprotein B-100 biogenesis
129. Cloning and regulation of hamster microsomal triglyceride transfer protein
130. Electrophysiological studies in five cases of abetalipoproteinemia
131. Studies concerning the defect in a patient with acanthrocytosis
132. Effects on prolonged vitamin E deficiency in the rat
133. The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins
134. Abnormal kinetics of red cell membrane cholesterol in acanthocytosis: Studies in genetic and experimental abetalipoproteinemia and in spur cell anaemia
135. Abetalipoproteinemia in adults: Role of vitamin therapy
136. Abetalipoproteinemia with an ApoB-100-lipoprotein (a) glycoprotein complex in plasma
137. Acanthrocytosis, pigmentory degeneration of the retina and ataxic neuropathy
138. Very low activated factor VII and reduced factor VII antigen in familial abetalipoproteinemia
139. The neuropathy of abetalipoproteinemia
140. Vitamin E, neurological function
141. Effect of large oral doses of vitamin E on the neurological sequlae of patients with abetalipoproteinemia
142. Long-term management of abetalipoproteinemia: Possible role for vitamin E
143. The role of vitamin E in the treatment of the neurogical features of abetalipoproteinemia and other disorders of fat absorption
144. Sterol balance in a patient with abetalipoproteinemia
145. Mutations of the microsomal triglyceride transfer protein gene in abetalipoproteinemia
146. Regulation of microsomal triglyceride transfer protein mRNA by endotoxin and cytokines
147. Progressive neuropathologic lesions in vitamin E deficient rhesus monkeys
148. Identification of domains in apolipoprotein B 100 that confer a high requirement for the microsomal triglyceride transfer protein
149. Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart
150. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia
151. The assembly and secretion of apolipoprotein B-containing lipoproteins
152. Ceroid pigment in human tissue
153. Acanthocytosis, short stature and disordered deep sensation in a 26-year-old patient
154. Genetic exclusion of apo-B gene in recessive abetalipoproteinemia
155. Quantitative chromatographic analysis of plasma and red blood cell lipids in patients with acanthocytosis
156. Modification des lipides plasmatiques apres ingestion d'huile chez trois enfants normaux et dans un cas d'absence congenitale des betalipoproteines
157. Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes
158. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice
159. Abetalipoproteinemia: New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease
160. A novel abetalipoproteinemia genotype
161. Surface binding and catabolism of low-density lipoprotein by circulating lymphocytes from patients with abetalipoproteinemia, with observations on sterol synthesis in lymphocytes from one patient
162. A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfideisomerase and causes abetaliproteinemia
163. Abetalipoproteinemia
164. Deficiencies of vitamin E, A in the rat: Retinal damage and lipopfuscin accumulation
165. Abetalipoproteinemia - A case report
166. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinemia
167. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells
168. On having no betalipoprotein: A syndrome comprising abetalipoproteinemia, acanthocytosis and steatorrhea
169. A study of the abormal lipoproteins in abetalipoproteinemia
170. Bassen-Kornzweig syndrome: Deficiency of serum betalipoprotein; a neuromuscular disorder ressembling Freidreich's ataxia, associated with steatorrhea, acanthocytosis, retinis pigmentosa and a disorder of lipid metabolism
171. Case records of the Massachusetts general hospital
172. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia
173. Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma
174. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein
175. The abetalipoproteinemia gene is a member of the vitellogenin family and encodes an α-helical domain
176. Incubation hemolysis and red cell metabolism in acanthocytosis
177. Demyelinating central nervous system disease, macular atrophy and acanthocytosis
178. Abetalipoproteinemia: Metabolic, endocrine, and electron-microscopic investigations
179. Electroretinographic responses following vitamin A therapy in abetalipoproteinemia
180. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma
181. Clinical picture mimicking Friedreich's ataxia associated with vitamin E deficiency and normal fat absorption
182. Abetalipoproteinemia associated with hepatic and atypical neurological disorders
183. Requirement of low density lipoproteins for the lysolecithin acyl transferase activity in human plasma: Assay of enzyme activity in abetalipoproteinemia
184. Molecular species of cholesterol esters formed in abetalipoproteinemia: Effect of apoprotein B-containing lipoproteins
185. Abnormal platelet functions in a patient with abetalipoproteinemia
186. Abetalipoproteinemia or Bassen-Kornzweig syndrome. Clinical, biochemical and electrophysiological features of two cases
187. Neurological symptoms in abetalipoproteinemia
188. Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia
189. Structure of the microsomal triglyceride transfer protein in complex with protein disulfide isomerase
190. Effects of chronic vitamin E deficiency in the nervous system of the rat
191. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism
192. Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein
193. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins
194. Discrimination between RRR- and all-racemic-tocopherols labeled with deuterium by patients with abetalipoproteinemia
195. Lack of tocopherol in pheripheral nerves of vitamin E-deficient patients with peripheral neuropathy
196. Ocular histopathologic changes in a case of abetalipoproteinemia
197. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfect COS-7 cells
198. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells
199. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McARH7777 cells
200. Etiology of the RBC phospholipid abnormalities in abetalipoproteinemia
201. Red-cell and plasma lipids in acanthocytosis
202. Studies on the absorptive defect for triglyceride in abetalipoproteinemia
203. Abetalipoproteinemia
204. Neuromuscular dysfunction and ultrastructural pathology in children with chronic cholestasis and vitamin E deficiency
205. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia
206. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex
207. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL Rabbits
208. Microsomal triglyceride transfer protein
209. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes
210. Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues
211. Peripheral neuropathy in abetalipoproteinemia
212. L'abetalipoproteinemie. A propos de deux cas
213. Abetalipoproteinemia, with special reference to the visual defect
214. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of apoB-containing lipoproteins
215. Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene